Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.53 USD
Change Today -0.009 / -0.35%
Volume 92.5K
TEAR On Other Exchanges
As of 2:31 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

tearlab corp (TEAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/15/14 - $5.97
52 Week Low
01/26/15 - $1.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TEARLAB CORP (TEAR)

Related News

No related news articles were found.

tearlab corp (TEAR) Related Businessweek News

No Related Businessweek News Found

tearlab corp (TEAR) Details

TearLab Corp. operates as an ophthalmic device company in the United States. It develops and markets lab-on-a-chip technologies that enable eye care practitioners to enhance standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The company’s TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

132 Employees
Last Reported Date: 03/13/15
Founded in 1996

tearlab corp (TEAR) Top Compensated Officers

Chairman, Chief Executive Officer and Secreta...
Total Annual Compensation: $347.2K
President and Chief Operating Officer
Total Annual Compensation: $74.5K
Chief Financial Officer and Treasurer
Total Annual Compensation: $172.3K
Vice President of Regulatory
Total Annual Compensation: $180.0K
Compensation as of Fiscal Year 2013.

tearlab corp (TEAR) Key Developments

TearLab Corporation Announces Consolidated Financial Results for the Full Year and Fourth Quarter Ended December 31, 2014

TearLab Corporation announced consolidated financial results for the full year and fourth quarter ended December 31, 2014. For the quarter, revenue was USD 5,297,000 compared to USD 4,438,000 in the same period of the prior year. Loss from operations was USD 7,083,000 compared to USD 5,504,000 in the same period of the prior year. Net loss was USD 6,940,000 or USD 0.21 per basic and diluted share against USD 4,151,000 or USD 0.17 per diluted share, last year. For the full year, revenue was USD 19,718,000 compared to USD 14,645,000 in the same period of the prior year. Loss from operations was USD 25,004,000 compared to USD 17,774,000 in the same period of the prior year. Net loss was USD 23,722,000 or USD 0.74 per diluted share against USD 28,990,000 or USD 0.94 per diluted share, last year.

TearLab Corporation Enters into $35 Million Term Loan Agreement with CRQ

TearLab Corporation announced that it has entered into a term loan agreement with CRG and certain of its affiliate funds. The Agreement provides TearLab with up to $35 million of available borrowing capacity. Under the terms of the Agreement, CRG will initially provide $15 million. Up to $20 million of additional funding will be available to TearLab, at its option, through September 2016, subject to the satisfaction of certain revenue milestones and other borrowing conditions. The Agreement has a term of six years and bears interest at 13% per annum, with quarterly, interest-only payments for the first four years. At the Company's option, during the first four years a portion of the interest payments may be compounded and paid together with the principal in the fifth and sixth years.

TearLab Corporation to Report Q4, 2014 Results on Mar 12, 2015

TearLab Corporation announced that they will report Q4, 2014 results on Mar 12, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEAR:US $2.53 USD -0.009

TEAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TEAR.
View Industry Companies

Industry Analysis


Industry Average

Valuation TEAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.0x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEARLAB CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at